An interview with Iain Macdougall (UK) during the 2010 ERA-EDTA meeting in Munich, Germany
Will hepcidin be an important marker for iron management?
Dr Macdougall discusses iron metabolism, focusing on the emerging role of the hepicidin as an iron deficiency marker in CKD patients during the XLVII ERA-EDTA Congress.
He outlines current knowledge of the molecular mechanisms of hepcidin as a gatekeeper of iron availability in the body, and stresses the potential importance of this marker in patients with CKD.
